Bullish
$CLVS just to be clear and educate some members on this board....the approval for prostate will not be coming soon. If you have invested in biotechs, it is a good idea to understand FDA timelines. The file was submitted in mid-November. The FDA takes 30 days to review the file on it’s merits and determine if it is acceptable and complete. That clearly happened since management announced the filing recently. Now the review clock starts... PDUFA dates are given to the company based on FDA assessment of unmet need. Either 6 months for priority review of 10 for standard. So..... please stop posting nonsense about prostate approval coming in days.
  • 1
  • 5